Suraksha Diagnostic Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, on behalf of all promoters and promoter group members of Suraksha Diagnostic Limited, has filed an annual declaration with BSE and NSE under SEBI's Takeover Regulations for FY ending 31 March 2025. The key declaration is that promoters have NOT created any encumbrance (pledge, lien, or charge) on their shares in the company during the financial year, other than what was already disclosed earlier. The filing includes a detailed list of individual promoters, promoter group members, and over 60 associated entities (LLPs, private limited companies, HUFs). Suraksha Diagnostic is a Kolkata-based diagnostic services company listed on both BSE (54293) and NSE (SURAKSHA).
This is a routine annual compliance filing with no material impact on the stock. The confirmation of no new encumbrance on promoter shares is mildly positive, suggesting the promoter group has not needed to pledge holdings for funding, which reduces near-term overhang risk on the stock.